Inactivation of HIV-1 chemokine co-receptor CXCR-4 by a novel intrakine strategy

Nature Medicine

Volumn 3, Issue 10, 1997, Pages 1110-1116

  Chen, Ji Dai ^a   Bai, Xuefan ^a   Yang, An Gang ^a   Cong, Yanping ^a   Chen, Si Yi ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; EXPRESSION VECTOR; FLOW CYTOMETRY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOID CELL LINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS PATHOGENESIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; B-LYMPHOCYTES; CELL LINE; CELL LINE, TRANSFORMED; CELLS, CULTURED; CHEMOKINES; CHEMOKINES, CXC; CYTOMEGALOVIRUS; GENETIC VECTORS; GIANT CELLS; HELA CELLS; HIV-1; HUMANS; LYMPHOCYTES; POLYMERASE CHAIN REACTION; RECEPTORS, CXCR4; RECEPTORS, HIV; RECOMBINANT FUSION PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0030842949     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1097-1110     Document Type: Article

References (43)

1. Feng, Y., Broder, C., Kennedy, P.E. & Berger, E.A. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane G protein-coupled receptor. Science 272, 809-810 (1996).
2. Bleul, C.C. et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829-833 (1996).
3. Oberlin, E. et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line adapted HIV-1. Nature 382, 833-835 (1996).
4. Cheng-Mayer, C., Tateno, T., Seto, D. & Levy, J. Biological features of HIV that correlate with virulence in the host. Science 240, 80-82 (1988).
5. Tersmette, M. et al. Association between biological properties of human immunodeficiency virus variants and risk for AIDS mortality. Lancet i, 983-985 (1989).
6. Roos, M.T.L. et al. Viral phenotype and immune response in primary human immunodeficiency virus type-1 infection. J. Infect. Dis. 165, 427-432 (1992).
7. Loetscher, M. T. et al. Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J. Biol. Chem. 269, 232-237 (1994).
8. Baggliolini, M., Dewald, B. & Moser, B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 55, 97-179 (1994).
9. Nagasawa, T., Kikutani, H. & Kishimoto, T. Molecular cloning and structure of a pre-B-cell growth stimulating factor. Proc. Natl. Acad. Sci. USA 91, 2305-2309 (1994).
10. Shirozu, M. et al. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 28, 495-500 (1995).
11. Marasco, W.A., Haseltine, W.A. & Chen, S.-Y. Design, intracellular expression, and activity of a human anti-HIV-1 gp120 single chain antibody. Proc. Natl. Acad. Sci. USA 90, 7889-7893 (1993).
12. Chen, S.-Y., Khouri, Y., Bagley, J. & Marasco, W.A. Combined intra- and extracellular immunization against HIV-1 infection with a human anti-gp120 antibody. Proc. Natl. Acad. Sci. USA 91, 5932-5936 (1994).
13. Chen, S.-Y., Bagley, J. & Marasco, W.A. Intracellular antibodies as a new class of therapeutic molecules for gene therapy. Hum. Gene Ther. 5, 595-601 (1994).
14. Buonocore, L. & Rose, J.K. Blockade of human immunodeficiency virus type 1 production in CD4+ T cells by an intracellular CD4 expressed under control of the viral long terminal repeat. Proc. Natl. Acad. Sci. USA 90, 2695-2699 (1993).
15. Field, J. et al. Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method. Mol. Cell. Biol. 8, 2159-2165 (1988).
16. Daniel, M.D. et al. Simian immunodeficiency virus from African Green monkeys. J. Virol. 62, 4123-4128 (1988).
17. Chen, S.-Y. et al. Potent anti-tumor activities of a new class of tumor-specific cytotoxic cells. Nature 385, 78-80 (1997).
18. Choe, H. et al. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85, 1135-1148 (1996).
19. Phillips, K., Gentry, T., McCowage, C., Gilboa, E. & Smith, C. Cell-surface markers for assessing gene transfer into human hematopoietic cells. Nature Med. 2, 1154-1156 (1996).
20. + T lymphocytes. Gene Ther. 3, 695-705 (1996).
21. Pear, W.S., Nolan, G.P., Scott, M.L. & Baltimore, D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90, 8392-8396 (1993).
22. Pear, W.S., Scott, M.L. & Nolan, G.P. Generation of high-titer, helper-free retroviruses by transient transfection. in Methods in Molecular Biology: Methods in Gene Therapy (ed. Robbins, P.) 41-57 (Humana Press, Totowa, NJ, 1997).
23. Yu, M., Poeschla, E. & Wong-Staal, F. Progress toward gene therapy for HIV-1 infection. Gene Ther. 1, 13-26 (1994).
24. Lippincott-Schwartz, J., Bonifacino, J.S., Yuan, L.C. & Klausner, R.D. Degradation from the endoplasmic reticulum: Disposing of newly synthesized proteins. Cell 54, 209-220 (1988).
25. Rose, J.K. & Doms, R.W. Regulation of protein export from the endoplasmic reticulum. Annu. Rev. Cell Biol. 4, 257-288 (1988).
26. Fra, A.M., Fagioli, C., Finazzi, D., Sitia, R. & Alberini, C.M. Quality control of ER synthesized proteins: Exposed thio group as a three-way switch mediating assembly, retention and degradation. EMBO J. 12, 4755-4761 (1993).
27. Kopito, R.R. ER quality control: The cytoplasmic connection. Cell 88, 427-430 (1997).
28. Van Zee, K. J. et al. Effects of intravenous IL-8 administration in nonhuman primates. J. Immunol. 148, 1746-1752 (1992).
29. Deng, H. et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661-666 (1996).
30. Alkhatib, G. et al. CC CCR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272, 1955-1958 (1996).
31. Doranz, B.J. et al. A dual-tropic primary HIV-1 isolate that uses fusin and the CC-chemokine receptors CCR-5, CCR-3, and CCR-2b as fusion cofactors. Cell 85, 1149-1158 (1996).
32. Dragic, T. et al. HIV-1 entry into CD4 cells is mediated by the chemokine receptor CC-CCR-5. Nature 381, 667-673 (1996).
33. Nagasawa, T. et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382, 635-638 (1996).
34. Liu, R. et al. Homozygous defect in HIV-1 co-receptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367-377 (1996).
35. Samson, M. et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 282, 722-725 (1996).
36. Dean, M. et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CCR5 structural gene. Science 273, 1856-1862 (1996).
37. Huang, Y. et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med. 2, 1240-1243 (1996).
38. Biti, R., Ffrench, R., Young, J., Bennetts, B., Stewart, G. & Liang, T. HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nature Med. 3, 252-253 (1997).
39. Michael, N.L. et al. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nature Med. 3, 338-340 (1997).
40. Yang, A.-G. & Chen, S.-Y. A new class of antigen-specific cytotoxic cells. Nature Biotechnol. 15, 46-51 (1997).
41. Chen, J.-D., Yang, Q., Yang, A., Marasco, W. & Chen, S.-Y. Intra- and extracellular immunization against HIV-1 infection with lymphocytes transduced with an anti-gp120 antibody gene using AAV vectors. Hum. Gene Ther. 7, 1515-1525 (1996).
42. Endres, M.J. et al. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87, 745-756 (1996).
43. Yang, A.-G., Bai, X., Huang, X.F., Yao, C. & Chen, S.-Y. Phenotypic knockout of chemokine CCR5 coreceptor by intrakines for HIV-1 therapy. Proc. Natl. Acad. Sci. USA (in the press).